Demystifying Moderna: Insights From 11 Analyst Reviews
Demystifying Moderna: Insights From 11 Analyst Reviews
揭秘moderna：11位分析師評測帶來的洞見
In examining recent analyst actions, we gain...Analysts' ratings for Moderna (NASDAQ:MRNA) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
11位分析師提供的分析師對Moderna（納斯達克股票代碼：MRNA）在上個季度的評級從看漲到看跌不等。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $140.55, with a high estimate of $214.00 and a low estimate of $80.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.19%.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲140.55美元，最高估計爲214.00美元，最低估計爲80.00美元。隨着分析師將平均目標股價下調了8.19％，情緒的負面轉變顯而易見。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細明細
In examining recent analyst actions, we gain...
在研究分析師最...
登入免費觀看全文
登入/註冊